Liposomal Amphotericin B

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment

Antifungal Drugs in Pulmonary Mucormycosis

Liver Transplant European Study Into the Prevention of Fungal Infection

Amphotericin Versus Posaconazole for Pulmonary Mucormycosis

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Liposomal Amphotericin in Disseminated Leishmaniasis

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment